Stern Adam K

No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
11
3 non-derivative · 8 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 10, 2026Option exercise(X)345K$0.35$121K417K
Jul 10, 2026Option exercise(X)630K$0.35$221K744K
Oct 31, 2025Option exercise(X)92K$0.64$59K113K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 10, 2026Other(J)141K$0.35$50K141K
Jul 10, 2026Grant(A)630K$0.35$221K630K
Jul 10, 2026Option exercise(X)345K$0.35$121K0
Jul 10, 2026Grant(A)345K$0.35$121K345K
Jul 10, 2026Option exercise(X)630K$0.35$221K0
Oct 31, 2025Option exercise(X)92K$0.64$59K630K
Oct 16, 2025Other(J)265$0.59$155265
Oct 16, 2025Other(J)800K$0.64$516K800K

Transaction Codes

X
Exercise of in-the-money derivative
J
Other acquisition / disposition
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000921895-26-002109) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Ask your agent about MTNB insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0000921895-26-002109"
Ask your agent
Use Arkolith to summarize insider buying and selling at Matinas BioPharma Holdings, Inc.
over the last 90 days and cite the filings.